PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F08P6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $278,947
Award facts
- Contract value 100% obligated
- $278,947.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $278,947.20 with an ultimate completion date of January 20, 2026, was awarded on January 19, 2026 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., by the Defense Logistics Agency's Medical Supply Chain. The contract was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with the place of performance located in Conshohocken, PA. The award represents a task order issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle valued through December 2026.
Amerisourcebergen Drug Corp supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent company, Cencora, Inc. (doing business as Amerisourcebergen), maintains significant federal contract relationships with the Defense Logistics Agency and Department of Veterans Affairs, demonstrating extensive capability in fulfilling critical pharmaceutical and medical commodity requirements for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The DLA Medical Supply Chain anticipates establishing future Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning Amerisourcebergen to continue serving key government healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2D826F08P6?
SPE2D826F08P6 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826F08P6 worth?
The government has obligated $278,947 on SPE2D826F08P6.
Is contract SPE2D826F08P6 an order under another contract?
Yes. SPE2D826F08P6 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D826F08P6 competed?
The extent of competition for SPE2D826F08P6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award